The Japan medical wearables market is projected to expand from approximately US$1.117 billion in 2025 to approximately US$7.394 billion by 2035, with a compound annual growth rate of 20.8%, according to a newly released forecast. Remote patient monitoring (RPM) is the leading application and is expected to drive growth.
The Japan medical wearables market is projected to reach approximately US$1.117 billion in 2025 and expand to approximately US$7.394 billion by 2035. Growth is expected to be driven by the aging population, the rising prevalence of chronic diseases, the spread of RPM and the emergence of AI-enabled devices, with the promotion of digital health also providing support.
By application, remote patient monitoring has historically accounted for approximately 41% and is expected to record the highest growth going forward. From a regulatory perspective, amendments to the Pharmaceuticals and Medical Devices Act (PMD Act) in May 2025 strengthened the accountability of marketing authorization holders, raising requirements for safety and quality management. Meanwhile, Novocure’s Optune Lua was reportedly approved in Japan in August 2025 and is cited as an example of a wearable therapeutic device.
Diagnostic and therapeutic devices are the main product categories, while device formats include patches, smartwatches, activity monitors and headbands. Data integration for RPM and the use of home healthcare and AI analysis are expected to support market expansion, while distribution models, including online channels, are also undergoing transformation.
In the competitive landscape, Google, Abbott, Philips and GE Healthcare are introduced as major companies. Other companies mentioned include OMRON Healthcare, Apple and Dexcom. Overall, the report highlights the transformation of Japan’s medical wearables market from everyday data collection into a digital healthcare platform integrating diagnosis, treatment and remote management.